Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade (Q42052058)
Jump to navigation
Jump to search
scientific article published on April 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade |
scientific article published on April 1999 |
Statements
1 reference
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade (English)
1 reference
A M Lincoff
1 reference
E J Topol
1 reference
R M Califf
1 reference
D J Kereiakes
1 reference
J E Tcheng
1 reference
T A Kelly
1 reference
G C Timmis
1 reference
N S Kleiman
1 reference
J E Booth
1 reference
C Balog
1 reference
C F Cabot
1 reference
K M Anderson
1 reference
H F Weisman
1 reference
1 April 1999
1 reference
1 reference
Identifiers
1 reference